Status
Conditions
Treatments
About
The purpose of this study is to see if it is safe and effective to give ritonavir plus nelfinavir to HIV-infected patients. This study will also see how ritonavir and nelfinavir are absorbed by the body and how they affect the level of HIV in the blood.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Patients must have:
Prior Medication:
Allowed:
Anti-HIV therapy other than protease inhibitor therapy.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following prior conditions are excluded:
Prior Medication:
Excluded:
Investigational drugs within 30 days prior to drug administration.
Prior treatment with licensed or investigational HIV protease inhibitor.
Positive urine screen for recreational drugs. NOTE:
The presence of cannabis is not exclusionary unless the investigator believes its use will interfere with patient compliance.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal